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The original article \[[@CR1]\] contains errors in Figs. [6](#Fig1){ref-type="fig"} and [8](#Fig2){ref-type="fig"}. The corrected figures can be shown ahead.Fig. 6Migratory tendency of GFP (+)/GFP (−) cells when treated with different hormone drugs. **a** and **b**) The number of migratory cells increased in the DHT groups of the A2780 + 20 and SKOV3 + 5 GFP (+)/GFP (−) cell lines. **c** and **d**) Notably, when treated with DHT, the number of GFP (+) migratory cells increased markedly compared with DMSO or DHT + ASC-J9; **e** and **f**) The number of migratory in A2780 + 20 and SKOV3 + 5 Nanog GFP (+) cells were also higher than that of the Nanog GFP (−) cells. For analysis, the cells number in four fields was calculated at 40× magnification. Bar: 100 μM. DHT: 10 nM, and ASC-J9: 5 μM. \*\**P* \< 0.01; \*\*\**P* \< 0.001Fig. 8AR signaling axis enhances the stemness characteristics of ovarian cancer cells. **a**) Sphere formation assays of the monoclonal GFP (+)/GFP (−) cells of the SKPV3 + 5 and A2780 + 20 cell lines. The sphere formation abilities of the GFP (+) cell lines were significantly stronger than those of the GFP (−) cell lines. Bar: 200 μM. **b**) Colony formation assays of the monoclonal GFP (+)/GFP (−) cells of the SKPV3 + 5 and A2780 + 20 cell lines. The clonal efficiency of the GFP (+) cells was higher than that of the GFP (−) cells. Bar: 200 μM. **c** and **d**) Androgen or inhibitor treatment in SKPV3 + 5 and A2780 + 20 GFP (+) cells. Sphere and colony formation were enhanced when DHT was added, while ASC-J9 decreased this effect. DMSO was used as the vehicle control. DHT: 10 nM, and ASC-J9: 5 μM; Bar: 100 μM. \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001
